Cytosorbents
CTSO
$0.82
Share price
1.24%
Change (1 day)
-66.71%
Change (1 year)
Categories
Cytosorbents (CTSO) - Cash on Hand
Cash on Hand as of December 2023 : $14.13 M
According to Cytosorbents's latest financial reports the company has $14.13 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cytosorbents - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $22.14 M | -57.53% |
| 2021-12-31 | $52.13 M | -27% |
| 2020-12-31 | $71.42 M | 483.87% |
| 2019-12-31 | $12.23 M | -45.31% |
| 2018-12-31 | $22.36 M | 29.14% |
| 2017-12-31 | $17.32 M | 230.24% |
| 2016-12-31 | $5.24 M | -30.15% |
| 2015-12-31 | $7.5 M | 35.3% |
| 2014-12-31 | $5.54 M | 154.23% |
| 2013-12-31 | $2.18 M | 26.23% |
| 2012-12-31 | $1.72 M | 45.73% |
| 2011-12-31 | $1.18 M | 12.41% |
| 2010-12-31 | $1.05 M | -33.84% |
| 2009-12-31 | $1.59 M | -45.89% |
| 2008-12-31 | $2.94 M | 1293.49% |
| 2007-12-31 | $0.21 M | -92.63% |
| 2006-12-31 | $2.87 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $0.86 B | 6,021.25% | 🇺🇸 USA |
 Hologic HOLX | $1.93 B | 13,572.68% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $81.45 M | 476.41% | 🇺🇸 USA |